Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see how well reduced intensity conditioning followed by a stem
cell transplant from a donor (allogeneic) works in treating patients with severe systemic
sclerosis. In an allogeneic stem cell transplant procedure, stem cells are taken from a
healthy donor and transplanted into the patient. Stem cells can be donated by a family member
or an unrelated donor who is a complete tissue type match.
Phase:
Phase 2
Details
Lead Sponsor:
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium